Clinical trials
Phase 2 Carcinoma, Hepatocellular trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 8 |
| Bayer | 2 |
| Jennerex Biotherapeutics | 2 |
| Adherex Technologies, Inc. | 1 |
| Alberta Health services | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Canadian Cancer Trials Group | 1 |
| Coherus Oncology, Inc. | 1 |
| Fore Biotherapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 28 |
| Liver Neoplasms | 9 |
| Ovarian Neoplasms | 4 |
| Cholangiocarcinoma | 3 |
| Urinary Bladder Neoplasms | 3 |
| Adrenocortical Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Esophageal Neoplasms | 2 |
| Fallopian Tube Neoplasms | 2 |
| Glioma | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.